SDC3 and adenocarcinoma: In adenocarcinomas, when positive, SDC3 showed moderate immunostaining throughout the cytoplasm of neoplastic epithelial cells of patients with Gleason 3 tumors (Figure 4H) and weak cytoplasmic and pericellular immunostaining in Gleason 4–5 tumors (Figure 4I).